May 26, 2020
7:5
For every 5 shares held, investors received 7. The price per share adjusted from $10.58 to $7.56.
The split itself did not change the total investment value.
Lionco Pharmaceutical Group Co., Ltd. Class A (SSE:603669) operates in the Pharmaceuticals: other industry.
Lionco Pharmaceutical Group Co., Ltd. Class A company overviewLionco Pharmaceutical Group Co., Ltd. Class A's most recent stock split was on May 26, 2020. It was a 7-for-5 forward split, so shareholders received 7 shares for every 5 they held.
Lionco Pharmaceutical Group Co., Ltd. Class A (SSE:603669) has split its stock 3 times: a 7-for-5 split on May 10, 2018, a 7-for-5 split on June 6, 2019, and a 7-for-5 split on May 26, 2020.
Lionco Pharmaceutical Group Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between May 10, 2018 and May 26, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Lionco Pharmaceutical Group Co., Ltd. Class A's 7-for-5 split on May 26, 2020, every 5 shares became 7 shares.
Lionco Pharmaceutical Group Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on May 26, 2020, 6 years ago. Companies announce splits in advance, and any new SSE:603669 split will appear on this page.
Already premium?